Skip to content
Back Home

Breakthrough Innovation for Cancer

Breakthrough Innovation for Cancer

  • Home
    • Company
    • History
    • News and press
  • Technology and products
    • RNA interference
    • Prostate
    • SXL01 and prostate cancers
    • SXL05 and tumor vascularization
  • Contact us
  • Français
‹
›
Home » Technology and products

Technology and products


SeleXel develops a portfolio of molecules for treating aggressive cancers.

  • RNA interference
  • Prostate
  • SXL01 : a breakthrough treatment for prostate cancers
  • SXL05 : reduction of tumor hypoxia and metastasis

© 2016 SeleXel